A

AYTU

Aytu Biopharma Inc

1.97

0.000.00%
After Hours: 1.960  -0.01  -0.51%19:55 06/18 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Revenue

81.00M

107.40M

96.67M

65.63M

27.63M

Net Income

-15.84M

-17.05M

-108.78M

-58.29M

-13.62M

ROE

-0.4724

-0.3991

-1.1846

-0.5012

-0.2668

ROA

-0.1245

-0.1244

-0.5395

-0.2783

-0.1449

EPS

-2.861

-5.1052

-74.0054

-69.6129

-60.2792

BVPS

4.6405

7.1335

23.895

100.0844

151.0121

Asset Turnover

0.6364

0.7837

0.4794

0.3133

0.2939

Debt-to-Asset

0.7653

0.7116

0.6651

0.4822

0.3802

Current Ratio

0.9946

1.0553

0.93

0.9616

2.6222

Quick Ratio

0.7916

0.8815

0.7616

0.8123

2.2745